on-bodyinjectordosing.com domain details, SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease

domain urls (10) domain links in (0) domain links out (8)

Description: Learn about SKYRIZI®, now approved to treat moderate to severe Crohn’s disease. See full Safety and Prescribing Information.

Crohn's Disease

Domain rank: 100000000

Indexed URLs from on-bodyinjectordosing.com website (10)

The links in column here only counts links from external domains.

found date
links in
url title
url
2022-07-21
0
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-19
0
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
0
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
0
SKYRIZI® (risankizumab-rzaa) for Adults with Moderate to Severe CD
2022-09-17
0
2022-07-21
0
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
0
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
0
2022-09-17
0
SKYRIZI® (risankizumab-rzaa) for Moderate to Severe Crohn’s disease
2022-07-21
0
SKYRIZI® (risankizumab-rzaa) for Adults with Moderate to Severe CD

Plain text list